Finally, we assessed expression of TMEM123 by FACS analysis in CD4+ and CD8+ T lymphocytes isolated ex vivo from paired cancerous and non-tumoral tissue samples (proximal, but not adjacent to cancer cells) (N=14) and from peripheral blood (N=11) (Table S2). Here, TMEM123 is linked to cancer.